Noninvasive Assessment of Fibrosis Regression after Direct-acting Antiviral Treatment in Hepatitis C Virus Patients.

BACKGROUND: New direct acting antiviral agent (DAA) therapies are associated with a high sustained virological response rate (SVR) in hepatitis C virus (HCV) patients. The understanding of the impact of SVR on fibrosis stage is limited. OBJECTIVES: To determine the effect of treatment with the DAAs on long-term liver fibrosis stages, as determined by shear-wave elastography (SWE) or FibroTest. METHODS: Fibrosis stage was determined at baseline and at 6-month intervals after end of treatment (EOT), using two-dimensional SWE or FibroTest©; APRI and FIB-4 scores. RESULTS: The study comprised 133 SVR12 patients. After a median follow-up of 15 months (range 6-33), liver fibrosis stage decreased by at least 1 stage in 75/133 patients (56%). Cirrhosis reversal was observed in 24/82 (29%). Repeated median liver stiffness SWE values in cirrhotic patients were 15.1 kPa at baseline (range 10.5-100), 13.4 kPa (range 5.5-51) at 6 months, and 11.4 kPa (range 6.1-35.8) at 12 months after EOT, P = 0.01. During the second year after EOT, no statistically significant differences in liver fibrosis stage in 12, 18, and 24 months were found. Splenomegaly was the only significant negative predictor of liver fibrosis regression during all time points of repetitive noninvasive assessment. CONCLUSIONS: Following successful DAA treatment, the majority of our HCV patients with advanced fibrosis demonstrated significant improvement, as assessed by non-invasive methods. Advanced fibrosis stage was a negative predictor of fibrosis regression. Longer follow-up periods are required to further establish the impact of DAAs treatment in HCV patients with advanced fibrosis.

Do psychological factors predict occurrence of influenza-like symptoms in vaccinated elderly residents of a sheltered home?

OBJECTIVES: A previously shown relation between psychological factors and the occurrence of flu has not been tested in elderly people, who are at the greatest risk of mortality from flu complications. This study examined whether psychological factors predict the occurrence of influenza-like symptoms (ILS) in elderly residents. DESIGN: A prospective correlation design was used. METHOD: Our sample included 70 elderly residents of a sheltered home (mean age 83.0 years) who were vaccinated against influenza and assessed for background, biomedical factors (e.g. number of illnesses) and psychological factors (e.g. hostility, depression, life-events, and social support). The occurrence of ILS during 2 subsequent winter months was evaluated by a nurse blind to patients' psychological data, according to explicit valid criteria and physicians' notes. RESULTS: Seventeen patients (24.3%) developed ILS. Number of medications, little physical activity, hostility, depression, and little social support significantly predicted ILS. In a multivariate analysis, only number of drugs (relative risk, RR: 1.54; 95% confidence interval, CI: 1.06-2.22) and hostility (RR = 1.18; 95% CI: 1.00-1.38) significantly and independently predicted occurrence of ILS. CONCLUSIONS: Psychological factors (particularly hostility) predict occurrence of ILS in an elderly sample. Possible behavioural and immunological mechanisms linking hostility to development of ILS are discussed. These findings add to the literature on psychological factors and flu, and may have implications for the prediction and prevention of flu in elderly people.